Effects of Inhaled Corticosteroids and Particle Size on Risk of Obstructive Sleep Apnea: A Large Retrospective Cohort Study
Open Access
- 6 October 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (19) , 7287
Abstract
Background: Inhaled corticosteroids (ICS) produce local effects on upper airway dilators that could increase the risk of developing obstructive sleep apnea (OSA). Given that the particle size of ICS changes their distribution, the particle size of ICS may impact the risk of developing OSA. Objectives: In this large retrospective study, we explore the relationship of ICS use and OSA in patients with asthma. In addition, we seek to determine if this relationship is affected by the particle size of ICS. Methods: Using electronic health records, we established a cohort of 29,816 asthmatics aged 12 and older with a diagnosis of asthma documented by ICD-9 or ICD-10 codes between January 2011 and August 2016. We performed analyses of variance and multivariate logistic regression analysis to determine the effects ICS on the diagnosis of OSA with sub-analysis by particle size of ICS. Results: Uncontrolled asthmatics showed increased odds of receiving a diagnosis of OSA whether when looking at ACT scores (adjusted odds ratio (aOR) 1.60, 95% CI 1.32–1.94) or PFT results (aOR 1.45, 95% CI 1.19–1.77). Users of ICS also had increased odds of OSA independent of asthma control (aOR 1.58, 95% CI 1.47–1.70). Notably, users of extra-fine particle ICS did not have significantly increased odds of having OSA compared to non-users of ICS (aOR 1.11, 95% CI 0.78–1.58). Conclusions: Use of ICS appears to be an independent risk factor for OSA. Notably, extra-fine particle size ICS do not appear to be associated with an increased risk of OSA.Keywords
This publication has 33 references indexed in Scilit:
- Lung penetration and patient adherence considerations in the management of asthma: role of extra fine formulationsJournal of Asthma and Allergy, 2013
- Particle size of inhaled corticosteroids: Does it matter?Journal of Allergy and Clinical Immunology, 2009
- In Vitro / In Vivo Comparisons in Pulmonary Drug DeliveryJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- Correlates of daytime sleepiness in patients with asthmaSleep Medicine, 2006
- Two-Dimensional and Three-Dimensional Imaging Show Ciclesonide Has High Lung Deposition and Peripheral Distribution: A Nonrandomized Study in Healthy VolunteersJournal of Aerosol Medicine, 2006
- Drug Delivery Performance of the Mometasone Furoate Dry Powder InhalerJournal of Aerosol Medicine, 2001
- FEV1 is associated with risk of asthma attacks in a pediatric populationJournal of Allergy and Clinical Immunology, 2001
- Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countriesEuropean Respiratory Journal, 1996
- IRREGULAR BREATHING AND HYPOXAEMIA DURING SLEEP IN CHRONIC STABLE ASTHMAThe Lancet, 1982